Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CDC7 | O00311 | 1/20 | 0.32 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29668501 | 1.00 | LMNA (0.46) | LMNAIDO1ADRA2AADORA2AHTT | |
| SCHEMBL5924277 | 0.88 | LMNA (0.46) | LMNAIDO1ADRA2AADORA2AHTT | |
| SCHEMBL2067816 | 0.82 | LMNA (0.46) | LMNAIDO1ADRA2AADORA2AHTT | |
| SCHEMBL29668443 | 0.82 | LMNA (0.46) | LMNAIDO1ADRA2AADORA2AHTT | |
| SCHEMBL1251696 | 0.81 | IDO1 (0.39) | LMNAIDO1ALDH1A1CDC7DBF4 | |
| Hydrochloric Acid SCHEMBL4932899 | 0.80 | LMNA (0.44) | LMNAIDO1ADRA2AADORA2AHTT | |
| SCHEMBL4639401 | 0.79 | LMNA (0.48) | LMNAIDO1ADRA2AADORA2AHTT | |
| SCHEMBL3668788 | 0.79 | LMNA (0.48) | LMNAIDO1ADRA2AADORA2AHTT | |
| SCHEMBL967510 | 0.79 | LMNA (0.36) | LMNANOS1 | |
| SCHEMBL11581915 | 0.78 | LMNA (0.39) | LMNAIDO1ALDH1A1KDM4ENOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110115116-B | Method for forming solderable solder deposits on contact pads | 德国艾托特克公司 | 2022-05-27 | — | — | CN | disclosed |
| US-11032914-B2 | Method of forming a solderable solder deposit on a contact pad | ATOTECH DEUTSCHLAND GMBH (DE) | 2021-06-08 | — | — | US | disclosed |
| EP-3560304-B1 | METHOD OF FORMING A SOLDERABLE SOLDER DEPOSIT ON A CONTACT PAD | ATOTECH DEUTSCHLAND GMBH (DE) | 2021-02-03 | — | — | EP | disclosed |
| US-20190350088-A1 | METHOD OF FORMING A SOLDERABLE SOLDER DEPOSIT ON A CONTACT PAD | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2019-11-14 | — | — | US | disclosed |
| EP-3560304-A1 | METHOD OF FORMING A SOLDERABLE SOLDER DEPOSIT ON A CONTACT PAD | ATOTECH Deutschland GmbH (DE) | 2019-10-30 | — | — | EP | disclosed |
| CN-110115116-A | Method for forming solderable solder deposits on contact pads | 德国艾托特克公司 | 2019-08-09 | — | — | CN | disclosed |
| EP-2377376-B1 | METHOD TO FORM SOLDER DEPOSITS ON SUBSTRATES | ATOTECH DEUTSCHLAND GMBH (DE) | 2019-08-07 | — | — | EP | disclosed |
| CN-101495464-B | Prokineticin 1 receptor antagonists | JANSSEN PHARMACEUTICA NV | 2014-03-05 | — | — | CN | disclosed |
| CN-103396398-A | Prokineticin 1 receptor antagonists | JANSSEN PHARMACEUTICA NV | 2013-11-20 | — | — | CN | disclosed |
| US-8507376-B2 | Method to form solder deposits on substrates | ATOTECH DEUTSCHLAND GMBH (DE) | 2013-08-13 | — | — | US | disclosed |
| EP-2377376-A1 | METHOD TO FORM SOLDER DEPOSITS ON SUBSTRATES | ATOTECH Deutschland GmbH (DE) | 2011-10-19 | — | — | EP | disclosed |
| US-20110189848-A1 | METHOD TO FORM SOLDER DEPOSITS ON SUBSTRATES | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2011-08-04 | — | — | US | disclosed |
| EP-2240485-A1 | TRICYCLIC COMPOUNDS HAVING CORTICOTROPIN-RELEASING FACTOR ANTAGONISTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Takeda Pharmaceutical Company Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| WO-2010046235-A1 | METHOD TO FORM SOLDER DEPOSITS ON SUBSTRATES | ATOTECH DEUTSCHLAND GMBH (DE) | 2010-04-29 | — | — | WO | disclosed |
| WO-2009093747-A1 | TRICYCLIC COMPOUNDS HAVING CORTICOTROPIN-RELEASING FACTOR ANTAGONISTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-07-30 | — | — | WO | disclosed |
| CN-101495464-A | Prokineticin 1 receptor antagonists | JANSSEN PHARMACEUTICA NV (BE) | 2009-07-29 | — | — | CN | disclosed |
| CN-101405002-A | Prokineticin 2 receptor antagonists | JANSSEN PHARMACEUTICA NV (BE) | 2009-04-08 | — | — | CN | disclosed |
| US-3935195-A | FLUORESCENT DYE | STERLING DRUG INC. (US) | 1976-01-27 | — | — | US | disclosed |